Evidence map›Paper›PMID 36233464›Full record

ArticleJournal of clinical medicine2022

Association between CHADS

Hyung Jun Kim, Moo-Seok Park, Joonsang Yoo, Young Dae Kim, Hyungjong Park, Byung Moon Kim, Oh Young Bang, Hyeon Chang Kim, Euna Han, Dong Joon Kim and 26 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 14 institutions in 1 country.

Hyung Jun KimDepartment of Neurology, Seoul Hospital, College of Medicine, Ewha Woman's University, Seoul 07804, Korea.ORCID 0000-0002-7518-9739
Moo-Seok ParkDepartment of Neurology, Seoul Hospital, College of Medicine, Ewha Woman's University, Seoul 07804, Korea.
Joonsang YooDepartment of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin 16995, Korea.ORCID 0000-0003-1169-6798
Young Dae KimDepartment of Neurology, Yonsei University College of Medicine, Seoul 03722, Korea.ORCID 0000-0001-5750-2616
Hyungjong ParkDepartment of Neurology, Keimyung University School of Medicine, Daegu 42601, Korea.
Byung Moon KimDepartment of Radiology, Yonsei University College of Medicine, Seoul 03722, Korea.
Oh Young BangDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Hyeon Chang KimDepartment of Preventive Medicine, Yonsei University College of Medicine, Seoul 03722, Korea.ORCID 0000-0001-7867-1240
Euna HanCollege of Pharmacy, Yonsei Institute for Pharmaceutical Research, Yonsei University, Incheon 21983, Korea.ORCID 0000-0003-2656-7059
Dong Joon KimDepartment of Radiology, Yonsei University College of Medicine, Seoul 03722, Korea.ORCID 0000-0002-7035-087X
JoonNyung HeoDepartment of Neurology, Yonsei University College of Medicine, Seoul 03722, Korea.ORCID 0000-0001-6287-6348
Jin Kyo ChoiDepartment of Neurology, Seoul Medical Center, Seoul 02053, Korea.ORCID 0000-0002-9528-4629
Kyung-Yul LeeDepartment of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Korea.
Hye Sun LeeBiostatistics Collaboration Unit, Department of Research Affairs, Yonsei University College of Medicine, Seoul 03722, Korea.ORCID 0000-0001-6328-6948
Dong Hoon ShinDepartment of Neurology, Gachon University Gil Medical Center, Incheon 21565, Korea.ORCID 0000-0002-1103-1983
Hye-Yeon ChoiDepartment of Neurology, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul 05278, Korea.ORCID 0000-0001-6291-3153
Sung-Il SohnDepartment of Neurology, Keimyung University School of Medicine, Daegu 42601, Korea.ORCID 0000-0002-6900-1242
Jeong-Ho HongDepartment of Neurology, Keimyung University School of Medicine, Daegu 42601, Korea.ORCID 0000-0002-8235-9855
Jong Yun LeeDepartment of Neurology, National Medical Center, Seoul 04564, Korea.ORCID 0000-0001-5857-5518
Jang-Hyun BaekDepartment of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Korea.ORCID 0000-0002-6733-0683
Gyu Sik KimDepartment of Neurology, National Health Insurance Service Ilsan Hospital, Goyang 10444, Korea.
Woo-Keun SeoDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.ORCID 0000-0002-4004-8434
Jong-Won ChungDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Seo Hyun KimDepartment of Neurology, Yonsei University Wonju College of Medicine, Wonju 26426, Korea.ORCID 0000-0001-5937-5729
Sang Won HanDepartment of Neurology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul 01757, Korea.
Joong Hyun ParkDepartment of Neurology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul 01757, Korea.
Jinkwon KimDepartment of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin 16995, Korea.ORCID 0000-0003-0156-9736
Yo Han JungDepartment of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Korea.ORCID 0000-0002-3048-4718
Han-Jin ChoDepartment of Neurology, Pusan National University School of Medicine, Busan 49241, Korea.
Seong Hwan AhnDepartment of Neurology, Chosun University School of Medicine, Gwangju 61453, Korea.ORCID 0000-0002-4778-491X
Sung Ik LeeDepartment of Neurology, Sanbon Hospital, Wonkwang University School of Medicine, Gunpo 15865, Korea.
Kwon-Duk SeoDepartment of Neurology, National Health Insurance Service Ilsan Hospital, Goyang 10444, Korea.ORCID 0000-0003-3154-8864
Yoonkyung ChangDepartment of Neurology, Mokdong Hospital, College of Medicine, Ewha Woman's University, Seoul 07985, Korea.ORCID 0000-0002-0345-2278
Hyo Suk NamDepartment of Neurology, Yonsei University College of Medicine, Seoul 03722, Korea.ORCID 0000-0002-4415-3995
Tae-Jin SongDepartment of Neurology, Seoul Hospital, College of Medicine, Ewha Woman's University, Seoul 07804, Korea.ORCID 0000-0002-9937-762X
SECRET Study Investigators
Yonsei University · KREwha Womans University · KRKeimyung University · KRSamsung Medical Center · KRInje University Sanggye Paik Hospital · KRNational Health Insurance Service Ilsan Hospital · KRChosun University · KRGachon University Gil Medical Center · KRKangbuk Samsung Hospital · KRKyung Hee University Hospital at Gangdong · KRNational Medical Center · KRPusan National University · KRSeoul Medical Center · KRWonkwang University · KR

Funding

Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education NRF-2021R1F1A1048113NIEHS NIH HHS 27302C0028Patient-Centered Clinical Research Coordinating Center (PACEN) funded by the Ministry of Health & Welfare, Republic of Korea HC19C0028
6 · The paper itself

Abstract

Background: CHADS2, CHA2DS2-VASc, ATRIA, and Essen stroke risk scores are used to estimate thromboembolism risk. We aimed to investigate the association between unfavorable outcomes and stroke risk scores in patients who received endovascular thrombectomy (EVT). Methods: This study was performed using data from a nationwide, multicenter registry to explore the selection criteria for patients who would benefit from reperfusion therapies. We calculated pre-admission CHADS2, CHA2DS2-VASc, ATRIA, and Essen scores for each patient who received EVT and compared the relationship between these scores and 3-month modified Rankin Scale (mRS) records. Results: Among the 404 patients who received EVT, 213 (52.7%) patients had unfavorable outcomes (mRS 3−6). All scores were significantly higher in patients with unfavorable outcomes than in those with favorable outcomes. Multivariable logistic regression analysis indicated that CHADS2 and the ATRIA score were positively correlated with unfavorable outcomes after adjusting for body mass index and variables with p < 0.1 in the univariable analysis (CHADS2 score: odds ratio [OR], 1.484; 95% confidence interval [CI], 1.290−1.950; p = 0.005, ATRIA score, OR, 1.128; 95% CI, 1.041−1.223; p = 0.004). Conclusions: The CHADS2 and ATRIA scores were positively correlated with unfavorable outcomes and could be used to predict unfavorable outcomes in patients who receive EVT.

Indexed as

endovascular thrombectomyfunctional outcomeischemic strokestroke risk score

Identifiers

PMID36233464
PMCPMC9570925
OpenAlexW4297235883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.